Period wise analysis [Bioanalytics]

posted by Compliance – India, 2012-03-10 08:11 (4830 d 01:57 ago) – Posting: # 8246
Views: 3,303

Dear All,

Can anyone tell me the FDA concern if we conduct the study sample analysis immediately after completion of respective period instead of conducting analysis of all periods together.

We want to do this because we want to expiated our submission process. However there is no stability issue.

Regards,

Compliance

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,683 registered users;
64 visitors (0 registered, 64 guests [including 43 identified bots]).
Forum time: 11:09 CEST (Europe/Vienna)

Nerds don’t just happen to dress informally.
They do it too consistently.
Consciously or not, they dress informally
as a prophylactic measure against stupidity.    Paul Graham

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5